Anthropic IPO market moves as traders reprice a $2 trillion debut

Polymarket has an active contract on whether Anthropic's IPO will debut at or above a $2 trillion valuation. The number traders are currently implying is not the story. The structure of the question is.

A $2 trillion IPO valuation for any company is not a prediction — it is a threshold test. Anthropic would need to price above every public technology company that has ever listed except a handful, and it would need to do so before achieving the revenue base those companies had when they crossed similar marks. The market is being asked to price a future fact against a present absence of public financials, which means the contract is pricing sentiment, not fundamentals. Sentiment moves faster than fundamentals. It also corrects faster.

The enforceability problem is quieter but more durable. An IPO valuation contract resolves on a number that has no single authoritative source until the company files a final prospectus and the shares price. Pre-IPO valuations are private market conventions — they are what the last round implies, not what a court would call a price. If Anthropic's bankers price the offering at $1.95 trillion on a fully diluted basis but the headline figure circulates as $2.1 trillion on a primary share count, the resolution condition becomes a definitional dispute before it becomes a legal one. I have seen this category of ambiguity in derivative contract disputes where the settlement reference rate was defined by market convention rather than statute. The convention held — until the convention changed.

There is also a timing layer. Anthropic has not filed publicly. The window between a company's last private round and its public pricing is when valuation compression is most common, because the scrutiny is suddenly different. Private investors set marks; public markets discover prices. The gap between those two activities is where the $2 trillion figure will either survive or not.

The consensus read seems to be that Anthropic's AI positioning makes a premium valuation defensible. I think that framing misses the actual variable. The question is not whether Anthropic is worth $2 trillion to someone. The question is whether a public market, in the quarter it actually lists, will pay that price in the offering itself. Those are different transactions with different clearing mechanics and different legal consequences for the contract.

The market for the contract is mispriced in the direction it always misprice technology IPOs: it weights the company's perceived importance over the market's actual willingness to pay at the moment of pricing. Importance and price have historically diverged at listing for companies that generate large pre-IPO narrative without proportionate pre-IPO revenue disclosure.